FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
BETA-VAL
betamethasone valerate
LOE Approaching
TOPICAL · CREAM
1983
NDA
30/100
BETADERM
betamethasone valerate
LOE Approaching
TOPICAL · CREAM
1983
NDA
30/100
BETADINE
povidone-iodine
LOE Approaching
Alcon
OPHTHALMIC · SOLUTION/DROPS
1986
NDA
30/100
BETAGAN
levobunolol hydrochloride
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
hypertensionglaucoma
1985
NDA
30/100
BETAGAN
levobunolol hydrochloride
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
hypertensionglaucoma
1989
NDA
30/100
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
LOE Approaching
Sandoz
TOPICAL · OINTMENT
1984
NDA
30/100
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
LOE Approaching
Sandoz
TOPICAL · CREAM
1984
NDA
30/100
BETAMETHASONE VALERATE
betamethasone valerate
LOE Approaching
Sandoz
TOPICAL · OINTMENT
1983
NDA
30/100
BETAMETHASONE VALERATE
betamethasone valerate
LOE Approaching
Sandoz
TOPICAL · LOTION
1983
NDA
30/100
BETAMETHASONE VALERATE
betamethasone valerate
LOE Approaching
Sandoz
TOPICAL · CREAM
1983
NDA
30/100
BETAPACE
sotalol hydrochloride
LOE Approaching
Enterprise Therapeutics
ORAL · TABLET
documentedlife-threatening ventricular arrhythmias+2
1992
NDA
30/100
BETAPACE AF
sotalol hydrochloride
LOE Approaching
Enterprise Therapeutics
ORAL · TABLET
documentedlife-threatening ventricular arrhythmias+2
2000
NDA
30/100
BETAPRONE
propiolactone
LOE Approaching
Forest Devices
IRRIGATION · SOLUTION
rabies in all age groups
1959
NDA
30/100
BETATREX
betamethasone valerate
LOE Approaching
TOPICAL · LOTION
1983
NDA
30/100
BETATREX
betamethasone valerate
LOE Approaching
TOPICAL · OINTMENT
1983
NDA
30/100
BETATREX
betamethasone valerate
LOE Approaching
TOPICAL · CREAM
1983
NDA
30/100
BETAXON
levobetaxolol hydrochloride
LOE Approaching
Alcon
OPHTHALMIC · SUSPENSION/DROPS
2000
NDA
30/100
BETHKIS
tobramycin inhalation
Peak
Chiesi
INHALATION · SOLUTION
cystic fibrosis patients with Pseudomonas aeruginosa
2012
NDA
30/100
BETIMOL
timolol
LOE Approaching
Thea Pharma
OPHTHALMIC · SOLUTION/DROPS
the treatment of elevated intraocular pressure in patients with ocular hypertensionopen-angle glaucoma+2
1995
SMNDA
30/100
BETOPTIC
betaxolol hydrochloride
LOE Approaching
Novartis
OPHTHALMIC · SOLUTION/DROPS
the treatment of ocular hypertensionchronic open-angle glaucoma+3
1985
NDA
30/100
BETOPTIC PILO
betaxolol hydrochloride; pilocarpine hydrochloride
LOE Approaching
Alcon
OPHTHALMIC · SUSPENSION/DROPS
elevated intraocular pressure in patients with primary open-angle glaucomaocular hypertension+2
1997
NDA
30/100
BETOPTIC S
betaxolol hydrochloride
LOE Approaching
Novartis
OPHTHALMIC · SUSPENSION/DROPS
elevated intraocular pressure (IOP) in patients with chronic open-angle glaucomaocular hypertension+2
1989
NDA
30/100
BEXTRA
valdecoxib
LOE Approaching
Pfizer
ORAL · TABLET
2001
SMNDA
30/100
BIAXIN
clarithromycin
LOE Approaching
AbbVie
ORAL · TABLET
mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditionsGranules for Oral Suspension) Pharyngitis/Tonsillitis due to Streptococcus pyogenes (The usual drug of choice in the treatment+13
1991
NDA
30/100
← PreviousPage 22 of 277Next →